GSA Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,413
Closed -$465K 2055
2024
Q2
$465K Buy
+1,413
New +$499K 0.03% 1014
2023
Q1
Sell
-1,161
Closed -$273K 1976
2022
Q4
$273K Sell
1,161
-2,461
-68% -$583K 0.03% 1001
2022
Q3
$891K Buy
3,622
+87
+2% +$26.5K 0.12% 211
2022
Q2
$1.07M Buy
+3,535
New +$1.15M 0.16% 118
2020
Q4
Sell
-1,495
Closed -$411K 1649
2020
Q3
$411K Buy
+1,495
New +$396K 0.07% 520
2020
Q2
Sell
-3,091
Closed -$471K 1163
2020
Q1
$471K Buy
+3,091
New +$476K 0.12% 198
2019
Q4
Sell
-5,004
Closed -$710K 1773
2019
Q3
$710K Buy
5,004
+2,045
+69% +$282K 0.1% 331
2019
Q2
$370K Buy
+2,959
New +$349K 0.04% 857
2018
Q2
Sell
-2,761
Closed -$244K 1966
2018
Q1
$244K Sell
2,761
-4,207
-60% -$394K 0.01% 1390
2017
Q4
$688K Buy
6,968
+2,913
+72% +$286K 0.04% 783
2017
Q3
$390K Sell
4,055
-7,927
-66% -$717K 0.03% 1108
2017
Q2
$1.13M Sell
11,982
-2,952
-20% -$272K 0.07% 469
2017
Q1
$1.22M Buy
14,934
+8,000
+115% +$669K 0.07% 520
2016
Q4
$588K Sell
6,934
-7,963
-53% -$626K 0.04% 891
2016
Q3
$1.11M Sell
14,897
-837
-5% -$66.4K 0.06% 555
2016
Q2
$1.19M Buy
+15,734
New +$1.15M 0.07% 520
2016
Q1
Sell
-17,134
Closed -$1.03M 1945
2015
Q4
$1.03M Buy
17,134
+2,601
+18% +$156K 0.05% 683
2015
Q3
$787K Sell
14,533
-1,401
-9% -$81.6K 0.04% 832
2015
Q2
$925K Sell
15,934
-1,300
-8% -$72.6K 0.04% 969
2015
Q1
$1.04M Buy
17,234
+8,100
+89% +$432K 0.04% 836
2014
Q4
$486K Buy
9,134
+4,261
+87% +$213K 0.03% 943
2014
Q3
$218K Sell
4,873
-14,619
-75% -$621K 0.01% 1476
2014
Q2
$822K Sell
19,492
-237
-1% -$10.2K 0.04% 792
2014
Q1
$869K Buy
+19,729
New +$929K 0.06% 417
2013
Q3
Sell
-8,802
Closed -$309K 1681
2013
Q2
$309K Buy
+8,802
New +$290K 0.04% 854

Other funds holding WST